# Interventional Study of Implantation of hESC-derived RPE in Patients With RP Due to Monogenic Mutation

> **NCT03963154** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Centre d'Etude des Cellules Souches** · enrollment: 7 (actual)

## Conditions studied

- Retinitis Pigmentosa

## Interventions

- **BIOLOGICAL:** Human Embryonic Stem Cell Derived Retinal Pigment Epithelium (RPE)

## Key facts

- **NCT ID:** NCT03963154
- **Lead sponsor:** Centre d'Etude des Cellules Souches
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-08-19
- **Primary completion:** 2023-06-22
- **Final completion:** 2026-12-15
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2023-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03963154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03963154, "Interventional Study of Implantation of hESC-derived RPE in Patients With RP Due to Monogenic Mutation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03963154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*